MA
Mital Ankur Kaneria
About Mital Ankur Kaneria
Data last updated:
Mital Ankur Kaneria is a Director at Dwirayu Pharma Private Limited (since 2023). The company operates in Paper. Dwirayu Pharma Private Limited reported revenue of ₹3.90 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dwirayu Pharma Private Limited U21001GJ2023PTC139863 | Director | 06 Apr 2023 | 2023 | ₹3.90 Cr (FY 2026) | Active |
Board colleagues of Mital Ankur Kaneria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaybhai Subodhbhai Maheta | 07766698 | Dwirayu Pharma Private Limited | Director |
| Nileshbhai Mansukhlal Thumar | 10446737 | Dwirayu Pharma Private Limited | Director |
| Rekha Nilesh Thumar | 10103904 | Dwirayu Pharma Private Limited | Director |
| Shilpaben Pankajbhai Butani | 10103903 | Dwirayu Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mital Ankur Kaneria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mital Ankur Kaneria
Mital Ankur Kaneria currently holds 1 directorship: Dwirayu Pharma Private Limited (Director, since 06 Apr 2023, revenue ₹3.90 Cr (FY 2026)).
Mital Ankur Kaneria was first appointed on 06 Apr 2023 as Director at Dwirayu Pharma Private Limited.
The current boards of Mital Ankur Kaneria's companies include Abhaybhai Subodhbhai Maheta (Dwirayu Pharma Private Limited), Nileshbhai Mansukhlal Thumar (Dwirayu Pharma Private Limited), Rekha Nilesh Thumar (Dwirayu Pharma Private Limited), Shilpaben Pankajbhai Butani (Dwirayu Pharma Private Limited).